Cargando…
Healthcare utilisation and costs in the diagnosis and treatment of progressive-fibrosing interstitial lung diseases
There are over 200 interstitial lung diseases (ILDs). In addition to patients with idiopathic pulmonary fibrosis (IPF), a percentage of patients with other ILDs also develop progressive fibrosis of the lung during their disease course. Patients with progressive-fibrosing ILDs may show limited respon...
Autores principales: | Holtze, Colin, Flaherty, Kevin, Kreuter, Michael, Luppi, Fabrizio, Moua, Teng, Vancheri, Carlo, Scholand, Mary B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488711/ https://www.ncbi.nlm.nih.gov/pubmed/30578337 http://dx.doi.org/10.1183/16000617.0078-2018 |
Ejemplares similares
-
Role of imaging in progressive-fibrosing interstitial lung diseases
por: Walsh, Simon L.F., et al.
Publicado: (2018) -
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2019) -
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022) -
Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020) -
Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures
por: Wijsenbeek, Marlies, et al.
Publicado: (2022)